Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study sheds light on deadly frog fungus
African clawed frog
African clawed frogs were thought to be responsible for the spread of Batrachochytrium dendrobatidis. 

African clawed frog not responsible for spread of lethal infection

A fungus thought to be one of the major drivers of amphibian decline has not been caused by exposure to infected colonies of African clawed frogs, according to research by the Universities of Bristol and Portsmouth.

Amphibian species have been in steady decline for decades. A major cause is thought to be the rapid global spread of a lethal fungus infection Batrachochytrium dendrobatidis (Bd).  One prominent theory is that African clawed frogs are responsible for the spread of the disease.

Exported from South Africa worldwide since the 1930s, African clawed frogs (Xenopus laevis) have been used in medical research, human pregnancy testing, and also kept as pets.  

It is thought that escaped or released toads infected with the fungus have been involved in spreading the infection to native species. However, this so-called 'out of Africa' theory was originally based on circumstantial evidence and has never been confirmed directly.

Researchers examined the occurrence of Bd in two areas of the UK -  Wales and Lincolnshire - where African clawed toads had been released and had established breeding colonies.

Extensive testing of the colonies revealed heavy infections of Bd. However, samples of the frogs, toads and newts gave no evidence of transfer of infection, nor declines in their populations that might have resulted from past disease.

Professor Richard Tinsley from the University of Bristol said the results certainly don't support the 'out-of-Africa' theory in the conditions found in the UK:

 “Our field studies provide a particularly robust test of the possibility of disease transfer: the population in Wales was established in the wild over half a century ago, so we would have expected any ill-effects to have become evident here.  But, there is still a need for similar comprehensive testing in countries elsewhere in the world where Xenopus has been introduced.

 “We still need to understand what prevented the spread of infection from Xenopus in our study areas – potentially including variations between strains of the fungus and natural resistance to these strains by native amphibians.  Knowledge of these factors controlling infection may help in regions where spread of the fungus is occurring rapidly.”

The study, ‘Chytrid fungus infections in laboratory and introduced Xenopus laevis populations: assessing the risks for U.K. native amphibians’ is published in Biological Conservation.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.